Current situation of programmed cell death protein 1/programmed cell death ligand 1 inhibitors in advanced triple-negative breast cancer

Triple-negative breast cancer (TNBC) has the worst prognosis among all molecular types of breast cancer. Because of the strong immunogenicity of TNBC cells, programmed death 1/programmed death ligand 1 (PD-1/PD-L1) inhibitors, two kinds of immune checkpoint blockade agents, might help improve the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yuehua, Liu, Xiaoran, Li, Kun, Li, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086576/
https://www.ncbi.nlm.nih.gov/pubmed/35685994
http://dx.doi.org/10.21147/j.issn.1000-9604.2022.02.07

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086576/
https://www.ncbi.nlm.nih.gov/pubmed/35685994
http://dx.doi.org/10.21147/j.issn.1000-9604.2022.02.07

Ejemplares similares